Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01488422 · ClinicalTrials.gov registry record · NA
Neural Correlates of Stress Reduction
A NA study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 140
- Enrollment target
NCT01488422: Completed NA study, sponsored by Massachusetts General Hospital.
NCT01488422 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 140 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (90% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01488422, a NA study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 140 participants
- Enrollment target
Study Summary
This study will identify neural mechanisms associated with changes in emotion regulation following participation in stress reduction programs.
Primary Outcome
Study participants will undergo an MRI scan before and after attending an 8-week stress reduction program.
Interventions
- BEHAVIORAL Stress Reduction
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 140 participants |
| Start Date | 2011-12 |
| Est. Completion | 2014-12 |
| Phase | NA |
What the finished NCT01488422 record still lists
NCT01488422 is an interventional study that assigns participants to a tested intervention. The registered 140 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (90% lower).
The record links to 0 conditions, and to 1 intervention - of which Stress Reduction is the first listed.
NCT01488422 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01488422 about?
NCT01488422 is a clinical study titled "Neural Correlates of Stress Reduction". This study will identify neural mechanisms associated with changes in emotion regulation following participation in stress reduction programs.
What is the current status of trial NCT01488422?
This trial is currently completed. It is a NA study. The enrollment target is 140 participants. The study started on 2011-12. Estimated completion is 2014-12.
What interventions are being tested in trial NCT01488422?
The interventions under investigation include: Stress Reduction (BEHAVIORAL).
Who is sponsoring clinical trial NCT01488422?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01488422's enrollment target sits among peer trials
140 713th of 2000 higher than 1,281 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01419561 · 140 participants · Phase 2
Natural History Study of the KSHV Inflammatory Cytokine Syndrome (KICS)
- NCT01624805 · 140 participants · Phase 2
Methylprednisolone, Horse Anti-Thymocyte Globulin, Cyclosporine, Filgrastim, and/or Pegfilgrastim or Pegfilgrastim Biosimilar in Treating Patients With Aplastic Anemia or Low or Intermediate-Risk Myelodysplastic Syndrome
- NCT02369770 · 140 participants · NA
Sensory-Motor Rehabilitation Post Stroke
- NCT02455193 · 140 participants · NA
Neuronal Effects of Exercise in Schizophrenia
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia